Delivery Order SPE2DB24D2205-SPE2DB24FDSVK

Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $35K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML. The $7,422.06 firm fixed-price contract has a completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to the U.S. federal government, including military treatment facilities and veterans' hospitals....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,031 units of Nitrofurantoin 25 mg/5 ml suspension in 240 ml bottles. The $74,193.86 contract has a performance period through March 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $15,539.37 firm fixed price delivery order is for the supply of 240 mL bottles of Nitrofurantoin 25 mg/5 mL suspension medication. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $22,134.03 order is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a performance period through May 4, 2022. Amerisourcebergen Drug Corp is the prime contractor and this order is placed under an indefinite delivery contract (IDC) with a potential value of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,607.92, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a firm fixed price and has a period of performance through May 14, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Nitrofurantoin 25 mg/5 ml suspension in 230 ml bottles. The contract has a ceiling value of $6,299.97 and an ultimate completion date of August 20, 2024. It is a firm fixed-price contract, and no set-aside was used. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies, including a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,719.71, is a delivery order for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4563062398 - NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a ceiling value of $43,999.35 and an ultimate completion date of December 12, 2023. It is a Firm Fixed Price contract, with no set-aside designation indicated....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,946.65 firm-fixed-price contract is for the delivery of 240 ml bottles of the antibiotic drug Nitrofurantoin 25 mg/5 ml suspension. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,492.31 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of November 21, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDSVK
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $34,591.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564312592 NITROFURANTOIN 25 MG/5 ML SUSP 230ML. This contract has an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract did not utilize a set-aside designation.

Generated 7/17/24, 9:03 AM